At a glance
ClinicalIndex Comparison RecordN/ACompleted· 16 enrolled
Drug / intervention
Continuous Passive Motiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Kyrobak Continuous Passive Motion Device for the Treatment of Chronic Low Back Pain: A Pilot Study
In Brief
A clinical study evaluating Continuous Passive Motion for Low Back Pain. Completed, enrolled 16 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the efficacy of the Kyrobak continuous passive motion home-use device in relieving low back pain, improving proprioception (balance and fall prevention) and improving the symmetry of muscle function on either side of the spine.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLow Back Pain
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartOct 2013
Primary CompletionDec 2013
First PostedJun 2014
TodayJul 2026
First PostedJun 4, 2014
Enrollment StartOct 1, 2013
Primary CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 12.1 years ago
Interventions
Continuous Passive Motiondevice
Daily self-treatments at home for 3 weeks, with up to three 10-minute treatment sessions per day